Global PD-1 and PD-L1 Monoclonal Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global PD-1 and PD-L1 Monoclonal Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global PD-1 and PD-L1 Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-1 and PD-L1 Monoclonal Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PD-1 and PD-L1 Monoclonal Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merk, Bristol-Myers Squibb Company, Roche, Pfizer and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
PD-1 and PD-L1 Monoclonal Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe PD-1 and PD-L1 Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 and PD-L1 Monoclonal Antibody, with price, sales, revenue and global market share of PD-1 and PD-L1 Monoclonal Antibody from 2018 to 2023.
Chapter 3, the PD-1 and PD-L1 Monoclonal Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 and PD-L1 Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 and PD-L1 Monoclonal Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 and PD-L1 Monoclonal Antibody.
Chapter 14 and 15, to describe PD-1 and PD-L1 Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global PD-1 and PD-L1 Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 and PD-L1 Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-1 and PD-L1 Monoclonal Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PD-1 and PD-L1 Monoclonal Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merk, Bristol-Myers Squibb Company, Roche, Pfizer and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
PD-1 and PD-L1 Monoclonal Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- PD-1
- PD-L1
- Lung Cancer
- Liver Cancer
- Esophageal Cancer
- Gastric Cancer
- Nasopharyngeal Carcinoma
- Head and Neck Cancer
- Other
- Merk
- Bristol-Myers Squibb Company
- Roche
- Pfizer
- AstraZeneca
- Junshi Biosciences
- Innovent
- Hengrui
- BeiGene
- Alphamab Oncology
- Cstone
- Akeso
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe PD-1 and PD-L1 Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 and PD-L1 Monoclonal Antibody, with price, sales, revenue and global market share of PD-1 and PD-L1 Monoclonal Antibody from 2018 to 2023.
Chapter 3, the PD-1 and PD-L1 Monoclonal Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 and PD-L1 Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 and PD-L1 Monoclonal Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 and PD-L1 Monoclonal Antibody.
Chapter 14 and 15, to describe PD-1 and PD-L1 Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of PD-1 and PD-L1 Monoclonal Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 PD-1
1.3.3 PD-L1
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Lung Cancer
1.4.3 Liver Cancer
1.4.4 Esophageal Cancer
1.4.5 Gastric Cancer
1.4.6 Nasopharyngeal Carcinoma
1.4.7 Head and Neck Cancer
1.4.8 Other
1.5 Global PD-1 and PD-L1 Monoclonal Antibody Market Size & Forecast
1.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (2018-2029)
1.5.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merk
2.1.1 Merk Details
2.1.2 Merk Major Business
2.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merk Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Junshi Biosciences
2.6.1 Junshi Biosciences Details
2.6.2 Junshi Biosciences Major Business
2.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Junshi Biosciences Recent Developments/Updates
2.7 Innovent
2.7.1 Innovent Details
2.7.2 Innovent Major Business
2.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Innovent Recent Developments/Updates
2.8 Hengrui
2.8.1 Hengrui Details
2.8.2 Hengrui Major Business
2.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hengrui Recent Developments/Updates
2.9 BeiGene
2.9.1 BeiGene Details
2.9.2 BeiGene Major Business
2.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BeiGene Recent Developments/Updates
2.10 Alphamab Oncology
2.10.1 Alphamab Oncology Details
2.10.2 Alphamab Oncology Major Business
2.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Alphamab Oncology Recent Developments/Updates
2.11 Cstone
2.11.1 Cstone Details
2.11.2 Cstone Major Business
2.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cstone Recent Developments/Updates
2.12 Akeso
2.12.1 Akeso Details
2.12.2 Akeso Major Business
2.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Akeso Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PD-1 AND PD-L1 MONOCLONAL ANTIBODY BY MANUFACTURER
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 and PD-L1 Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2022
3.5 PD-1 and PD-L1 Monoclonal Antibody Market: Overall Company Footprint Analysis
3.5.1 PD-1 and PD-L1 Monoclonal Antibody Market: Region Footprint
3.5.2 PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Type Footprint
3.5.3 PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2018-2029)
4.2 North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.3 Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.5 South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
5.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2018-2029)
5.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2018-2029)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
7.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
7.3 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
7.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
10.2 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
10.3 South America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
10.3.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
12.2 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
12.3 PD-1 and PD-L1 Monoclonal Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PD-1 and PD-L1 Monoclonal Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 and PD-L1 Monoclonal Antibody
13.3 PD-1 and PD-L1 Monoclonal Antibody Production Process
13.4 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
14.3 PD-1 and PD-L1 Monoclonal Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of PD-1 and PD-L1 Monoclonal Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 PD-1
1.3.3 PD-L1
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Lung Cancer
1.4.3 Liver Cancer
1.4.4 Esophageal Cancer
1.4.5 Gastric Cancer
1.4.6 Nasopharyngeal Carcinoma
1.4.7 Head and Neck Cancer
1.4.8 Other
1.5 Global PD-1 and PD-L1 Monoclonal Antibody Market Size & Forecast
1.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (2018-2029)
1.5.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merk
2.1.1 Merk Details
2.1.2 Merk Major Business
2.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merk Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Junshi Biosciences
2.6.1 Junshi Biosciences Details
2.6.2 Junshi Biosciences Major Business
2.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Junshi Biosciences Recent Developments/Updates
2.7 Innovent
2.7.1 Innovent Details
2.7.2 Innovent Major Business
2.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Innovent Recent Developments/Updates
2.8 Hengrui
2.8.1 Hengrui Details
2.8.2 Hengrui Major Business
2.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hengrui Recent Developments/Updates
2.9 BeiGene
2.9.1 BeiGene Details
2.9.2 BeiGene Major Business
2.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BeiGene Recent Developments/Updates
2.10 Alphamab Oncology
2.10.1 Alphamab Oncology Details
2.10.2 Alphamab Oncology Major Business
2.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Alphamab Oncology Recent Developments/Updates
2.11 Cstone
2.11.1 Cstone Details
2.11.2 Cstone Major Business
2.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cstone Recent Developments/Updates
2.12 Akeso
2.12.1 Akeso Details
2.12.2 Akeso Major Business
2.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Akeso Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PD-1 AND PD-L1 MONOCLONAL ANTIBODY BY MANUFACTURER
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 and PD-L1 Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2022
3.5 PD-1 and PD-L1 Monoclonal Antibody Market: Overall Company Footprint Analysis
3.5.1 PD-1 and PD-L1 Monoclonal Antibody Market: Region Footprint
3.5.2 PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Type Footprint
3.5.3 PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2018-2029)
4.2 North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.3 Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.5 South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
5.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2018-2029)
5.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2018-2029)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
7.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
7.3 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
7.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
10.2 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
10.3 South America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
10.3.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
12.2 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
12.3 PD-1 and PD-L1 Monoclonal Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PD-1 and PD-L1 Monoclonal Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 and PD-L1 Monoclonal Antibody
13.3 PD-1 and PD-L1 Monoclonal Antibody Production Process
13.4 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
14.3 PD-1 and PD-L1 Monoclonal Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merk Basic Information, Manufacturing Base and Competitors
Table 4. Merk Major Business
Table 5. Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 6. Merk PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merk Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 11. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 16. Roche PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 21. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 26. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 29. Junshi Biosciences Major Business
Table 30. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 31. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Junshi Biosciences Recent Developments/Updates
Table 33. Innovent Basic Information, Manufacturing Base and Competitors
Table 34. Innovent Major Business
Table 35. Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 36. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Innovent Recent Developments/Updates
Table 38. Hengrui Basic Information, Manufacturing Base and Competitors
Table 39. Hengrui Major Business
Table 40. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 41. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hengrui Recent Developments/Updates
Table 43. BeiGene Basic Information, Manufacturing Base and Competitors
Table 44. BeiGene Major Business
Table 45. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 46. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BeiGene Recent Developments/Updates
Table 48. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 49. Alphamab Oncology Major Business
Table 50. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 51. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Alphamab Oncology Recent Developments/Updates
Table 53. Cstone Basic Information, Manufacturing Base and Competitors
Table 54. Cstone Major Business
Table 55. Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 56. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cstone Recent Developments/Updates
Table 58. Akeso Basic Information, Manufacturing Base and Competitors
Table 59. Akeso Major Business
Table 60. Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 61. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Akeso Recent Developments/Updates
Table 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 64. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in PD-1 and PD-L1 Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and PD-1 and PD-L1 Monoclonal Antibody Production Site of Key Manufacturer
Table 68. PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Type Footprint
Table 69. PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Application Footprint
Table 70. PD-1 and PD-L1 Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 71. PD-1 and PD-L1 Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 73. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 74. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 79. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 80. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 86. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 91. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 92. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 93. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 94. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 95. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 96. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 99. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 100. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 101. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 102. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 103. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 104. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 107. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 108. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 109. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 110. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 111. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 112. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 115. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 116. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 117. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 118. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 119. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 120. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 123. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 124. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 125. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 126. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 127. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 128. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 130. PD-1 and PD-L1 Monoclonal Antibody Raw Material
Table 131. Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody Raw Materials
Table 132. PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
Table 133. PD-1 and PD-L1 Monoclonal Antibody Typical Customers
Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merk Basic Information, Manufacturing Base and Competitors
Table 4. Merk Major Business
Table 5. Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 6. Merk PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merk Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 11. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 16. Roche PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 21. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 26. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 29. Junshi Biosciences Major Business
Table 30. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 31. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Junshi Biosciences Recent Developments/Updates
Table 33. Innovent Basic Information, Manufacturing Base and Competitors
Table 34. Innovent Major Business
Table 35. Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 36. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Innovent Recent Developments/Updates
Table 38. Hengrui Basic Information, Manufacturing Base and Competitors
Table 39. Hengrui Major Business
Table 40. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 41. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hengrui Recent Developments/Updates
Table 43. BeiGene Basic Information, Manufacturing Base and Competitors
Table 44. BeiGene Major Business
Table 45. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 46. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BeiGene Recent Developments/Updates
Table 48. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 49. Alphamab Oncology Major Business
Table 50. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 51. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Alphamab Oncology Recent Developments/Updates
Table 53. Cstone Basic Information, Manufacturing Base and Competitors
Table 54. Cstone Major Business
Table 55. Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 56. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cstone Recent Developments/Updates
Table 58. Akeso Basic Information, Manufacturing Base and Competitors
Table 59. Akeso Major Business
Table 60. Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 61. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Akeso Recent Developments/Updates
Table 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 64. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in PD-1 and PD-L1 Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and PD-1 and PD-L1 Monoclonal Antibody Production Site of Key Manufacturer
Table 68. PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Type Footprint
Table 69. PD-1 and PD-L1 Monoclonal Antibody Market: Company Product Application Footprint
Table 70. PD-1 and PD-L1 Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 71. PD-1 and PD-L1 Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 73. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 74. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 79. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 80. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 86. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 91. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 92. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 93. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 94. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 95. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 96. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 99. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 100. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 101. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 102. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 103. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 104. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 107. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 108. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 109. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 110. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 111. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 112. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 115. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 116. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 117. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 118. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2018-2023) & (Units)
Table 119. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Country (2024-2029) & (Units)
Table 120. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2018-2023) & (Units)
Table 123. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Type (2024-2029) & (Units)
Table 124. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2018-2023) & (Units)
Table 125. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Application (2024-2029) & (Units)
Table 126. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2018-2023) & (Units)
Table 127. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity by Region (2024-2029) & (Units)
Table 128. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 130. PD-1 and PD-L1 Monoclonal Antibody Raw Material
Table 131. Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody Raw Materials
Table 132. PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
Table 133. PD-1 and PD-L1 Monoclonal Antibody Typical Customers
LIST OF FIGURES
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Picture
Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Type in 2022
Figure 4. PD-1 Examples
Figure 5. PD-L1 Examples
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Application in 2022
Figure 8. Lung Cancer Examples
Figure 9. Liver Cancer Examples
Figure 10. Esophageal Cancer Examples
Figure 11. Gastric Cancer Examples
Figure 12. Nasopharyngeal Carcinoma Examples
Figure 13. Head and Neck Cancer Examples
Figure 14. Other Examples
Figure 15. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (2018-2029) & (Units)
Figure 18. Global PD-1 and PD-L1 Monoclonal Antibody Average Price (2018-2029) & (US$/Unit)
Figure 19. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of PD-1 and PD-L1 Monoclonal Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 26. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Type (2018-2029)
Figure 33. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Application (2018-2029)
Figure 36. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 41. United States PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 57. China PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. PD-1 and PD-L1 Monoclonal Antibody Market Drivers
Figure 78. PD-1 and PD-L1 Monoclonal Antibody Market Restraints
Figure 79. PD-1 and PD-L1 Monoclonal Antibody Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody in 2022
Figure 82. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
Figure 83. PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Picture
Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Type in 2022
Figure 4. PD-1 Examples
Figure 5. PD-L1 Examples
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Application in 2022
Figure 8. Lung Cancer Examples
Figure 9. Liver Cancer Examples
Figure 10. Esophageal Cancer Examples
Figure 11. Gastric Cancer Examples
Figure 12. Nasopharyngeal Carcinoma Examples
Figure 13. Head and Neck Cancer Examples
Figure 14. Other Examples
Figure 15. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity (2018-2029) & (Units)
Figure 18. Global PD-1 and PD-L1 Monoclonal Antibody Average Price (2018-2029) & (US$/Unit)
Figure 19. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of PD-1 and PD-L1 Monoclonal Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 26. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value (2018-2029) & (USD Million)
Figure 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Type (2018-2029)
Figure 33. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Application (2018-2029)
Figure 36. Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 41. United States PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 57. China PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. PD-1 and PD-L1 Monoclonal Antibody Market Drivers
Figure 78. PD-1 and PD-L1 Monoclonal Antibody Market Restraints
Figure 79. PD-1 and PD-L1 Monoclonal Antibody Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody in 2022
Figure 82. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
Figure 83. PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
